Lv1
30 积分 2024-11-25 加入
Bypassing adverse injection reactions to nanoparticles through shape modification and attachment to erythrocytes
17天前
已完结
Efficacy and Safety of the Third‐Generation Tyrosine Kinase Inhibitor Olverembatinib in Combination With Inotuzumab Ozogamicin for the Treatment of Adult Philadelphia Chromosome‐Positive Acute Lymphoblastic Leukemia Patients With Refractory/Relapsed Disease or Persistent Minimal Residual Disease Bridging to Hematopoietic Stem Cell Transplantation
5个月前
已完结
皖公网安备34019202002308
